Influenza Diagnostics Market Analysis by Test Type (Traditional Diagnostic Tests, Molecular Diagnostic Tests), by End User (Clinical Laboratories, Hospitals), and by Region - Forecast to 2029

Request Sample Page

The global influenza diagnostics market size is estimated to be USD 843.5 million in 2021 and is expected to witness a CAGR of 7.89% during the forecast period. Increase in cases of influenza is a key driver for the growth of the global influenza diagnostics market. Additionally, growing research in the field of influenza and rise in demand for rapid disease diagnosis in the influenza diagnostics market are some of the other drivers propelling the market growth. Nevertheless, increasing expenditure in healthcare and inconsistency in test sensitivity and specificity in the diagnosis of influenza are expected to restrain the global market growth.

Global Influenza Diagnostics Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Test Type

Based on test type, the market is categorized into traditional diagnostic tests, molecular diagnostic tests, and other molecular tests. In 2021, the traditional diagnostic tests segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the increasing adoption of cost-effective and faster diagnostic tests worldwide. The molecular diagnostic segment is anticipated to grow at a profitable CAGR during the forecast period, due to the launch of new products and shift towards molecular diagnostics are the key factors driving the market worldwide.

By End User

Based on end user, the market is categorized into clinical laboratories, hospitals, and other end users. In 2021, the hospitals segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the growing diagnosis of influenza diseases in hospitals worldwide. The clinical laboratories segment is anticipated to grow at a profitable CAGR during the forecast period, due to the high rate of penetration of these laboratories in developed regions.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the strong emphasis of the U.S. CDC on regulating the disease rates, increase in public awareness along with the accessibility of a wide range of diagnostic procedures, and accessibility of technologically advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the adoption of new and developed technologies, increase in awareness among the people, high population mass, and substantial growth in disease burden, are the major factors in this region.

Competitor Insights

Some of the key players in the influenza diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland); Quidel Corporation (U.S.); Thermo Fisher Scientific (U.S.); Abbott Laboratories (U.S.); Hologic (U.S.); Becton, Dickinson, and Company (U.S.); DiaSorin S.p.A (Italy); Luminex Corporation (U.S.); Meridian Bioscience (U.S.); and GenMark Diagnostics (U.S.). The leading players operating in the influenza diagnostics industry are adopting various strategies including R&D investments, adoption of advanced techniques, new product launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The influenza diagnostics market report is categorized into the following segments and subsegments:

Influenza Diagnostics Market, By Test Type (Revenue, USD Million, 2021 – 2029)

  • Traditional Diagnostic Tests
    • RIDT
    • Viral Culture
    • DFA
    • Serological Assays
  • Molecular Diagnostic Tests
    • RT-PCR
    • Isothermal Nucleic Acid Amplification Tests
      • Transcription-Mediated Amplification-Based Assays
      • Loop-Mediated Isothermal Amplification-Based Assays
      • Nucleic Acid Sequence-Based Amplification Tests
    • Other INAAT Tests
  • Other Molecular Tests

Influenza Diagnostics Market, By End User (Revenue, USD Million, 2021 – 2029)

  • Clinical Laboratories
  • Hospitals
  • Other End Users

Influenza Diagnostics Market, By Region (Revenue, USD Million, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Influenza Diagnostics Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Influenza Diagnostic Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Influenza Diagnostic
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Influenza Diagnostic Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Test type
    1. RT-PCR
      1. RT-PCR Market Forecast, 2021-2029 (USD Million)
    2. Cell culture
      1. Cell culture Market Forecast, 2021-2029 (USD Million)
    3. RIDT
      1. RIDT Market Forecast, 2021-2029 (USD Million)
    4. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by End use
    1. POCT
      1. POCT Market Forecast, 2021-2029 (USD Million)
    2. Laboratories
      1. Laboratories Market Forecast, 2021-2029 (USD Million)
    3. Hospitals
      1. Hospitals Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Influenza Diagnostic Market
    1. North America Influenza Diagnostic Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
        2. Market Size and Forecast by End use, 2021-2029 (USD Million)
      2. S. Influenza Diagnostic Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
          2. Market Size and Forecast by End use, 2021-2029 (USD Million)
        2. Canada Influenza Diagnostic Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
            2. Market Size and Forecast by End use, 2021-2029 (USD Million)
  1. Europe Influenza Diagnostic Market
    1. Europe Influenza Diagnostic Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
        2. Market Size and Forecast by End use, 2021-2029 (USD Million)
      2. Germany Influenza Diagnostic Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
          2. Market Size and Forecast by End use, 2021-2029 (USD Million)
        2. UK Influenza Diagnostic Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
            2. Market Size and Forecast by End use, 2021-2029 (USD Million)
          2. France Influenza Diagnostic Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
              2. Market Size and Forecast by End use, 2021-2029 (USD Million)
            2. Spain Influenza Diagnostic Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
                2. Market Size and Forecast by End use, 2021-2029 (USD Million)
              2. Italy Influenza Diagnostic Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by End use, 2021-2029 (USD Million)
                2. Rest of Europe Influenza Diagnostic Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by End use, 2021-2029 (USD Million)
  1. Asia Pacific Influenza Diagnostic Market
    1. Asia Pacific Influenza Diagnostic Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
        2. Market Size and Forecast by End use, 2021-2029 (USD Million)
      2. Japan Influenza Diagnostic Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
          2. Market Size and Forecast by End use, 2021-2029 (USD Million)
        2. China Influenza Diagnostic Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
            2. Market Size and Forecast by End use, 2021-2029 (USD Million)
          2. India Influenza Diagnostic Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
              2. Market Size and Forecast by End use, 2021-2029 (USD Million)
            2. South Korea Influenza Diagnostic Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
                2. Market Size and Forecast by End use, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia Influenza Diagnostic Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by End use, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Influenza Diagnostic Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by End use, 2021-2029 (USD Million)
  1. Latin America Influenza Diagnostic Market
    1. Latin America Influenza Diagnostic Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
        2. Market Size and Forecast by End use, 2021-2029 (USD Million)
      2. Brazil Influenza Diagnostic Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
          2. Market Size and Forecast by End use, 2021-2029 (USD Million)
        2. Mexico Influenza Diagnostic Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
            2. Market Size and Forecast by End use, 2021-2029 (USD Million)
          2. Argentina Influenza Diagnostic Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
              2. Market Size and Forecast by End use, 2021-2029 (USD Million)
            2. Rest of Latin America Influenza Diagnostic Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
                2. Market Size and Forecast by End use, 2021-2029 (USD Million)
  1. MEA Influenza Diagnostic Market
    1. MEA Influenza Diagnostic Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
        2. Market Size and Forecast by End use, 2021-2029 (USD Million)
      2. GCC Influenza Diagnostic Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
          2. Market Size and Forecast by End use, 2021-2029 (USD Million)
        2. South Africa Influenza Diagnostic Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
            2. Market Size and Forecast by End use, 2021-2029 (USD Million)
          2. Rest of MEA Influenza Diagnostic Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Test type, 2021-2029 (USD Million)
              2. Market Size and Forecast by End use, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Danaher Corporation (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Siemens Healthineers (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Thermo Fisher Scientific, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Hoffmann-LA Roche AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Abbott Laboratories, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Hologic, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. bioMérieux SA (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Quidel Corporation (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Becton, Dickinson and Company (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. Meridian Bioscience (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. GenMark Diagnostics, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Luminex Corporation (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Tecan Trading AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. DiaSorin SA (Italy)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. altona Diagnostics GmbH (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports